Cargando…
Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer’s Disease Mice
Alzheimer’s disease (AD) is the most common cause of senile dementia and one of the greatest medical, social, and economic challenges. According to a dominant theory, amyloid-β (Aβ) peptide is a key AD pathogenic factor. Aβ-soluble species interfere with synaptic functions, aggregate gradually, form...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018932/ https://www.ncbi.nlm.nih.gov/pubmed/33417228 http://dx.doi.org/10.1007/s12035-020-02270-0 |
_version_ | 1783674278069141504 |
---|---|
author | Fonar, Gennadiy Polis, Baruh Sams, Dev Sharan Levi, Almog Malka, Assaf Bal, Natalia Maltsev, Alexander Elliott, Evan Samson, Abraham O. |
author_facet | Fonar, Gennadiy Polis, Baruh Sams, Dev Sharan Levi, Almog Malka, Assaf Bal, Natalia Maltsev, Alexander Elliott, Evan Samson, Abraham O. |
author_sort | Fonar, Gennadiy |
collection | PubMed |
description | Alzheimer’s disease (AD) is the most common cause of senile dementia and one of the greatest medical, social, and economic challenges. According to a dominant theory, amyloid-β (Aβ) peptide is a key AD pathogenic factor. Aβ-soluble species interfere with synaptic functions, aggregate gradually, form plaques, and trigger neurodegeneration. The AD-associated pathology affects numerous systems, though the substantial loss of cholinergic neurons and α7 nicotinic receptors (α7AChR) is critical for the gradual cognitive decline. Aβ binds to α7AChR under various experimental settings; nevertheless, the functional significance of this interaction is ambiguous. Whereas the capability of low Aβ concentrations to activate α7AChR is functionally beneficial, extensive brain exposure to high Aβ concentrations diminishes α7AChR activity, contributes to the cholinergic deficits that characterize AD. Aβ and snake α-neurotoxins competitively bind to α7AChR. Accordingly, we designed a chemically modified α-cobratoxin (mToxin) to inhibit the interaction between Aβ and α7AChR. Subsequently, we examined mToxin in a set of original in silico, in vitro, ex vivo experiments, and in a murine AD model. We report that mToxin reversibly inhibits α7AChR, though it attenuates Aβ-induced synaptic transmission abnormalities, and upregulates pathways supporting long-term potentiation and reducing apoptosis. Remarkably, mToxin demonstrates no toxicity in brain slices and mice. Moreover, its chronic intracerebroventricular administration improves memory in AD-model animals. Our results point to unique mToxin neuroprotective properties, which might be tailored for the treatment of AD. Our methodology bridges the gaps in understanding Aβ-α7AChR interaction and represents a promising direction for further investigations and clinical development. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12035-020-02270-0. |
format | Online Article Text |
id | pubmed-8018932 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-80189322021-04-16 Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer’s Disease Mice Fonar, Gennadiy Polis, Baruh Sams, Dev Sharan Levi, Almog Malka, Assaf Bal, Natalia Maltsev, Alexander Elliott, Evan Samson, Abraham O. Mol Neurobiol Article Alzheimer’s disease (AD) is the most common cause of senile dementia and one of the greatest medical, social, and economic challenges. According to a dominant theory, amyloid-β (Aβ) peptide is a key AD pathogenic factor. Aβ-soluble species interfere with synaptic functions, aggregate gradually, form plaques, and trigger neurodegeneration. The AD-associated pathology affects numerous systems, though the substantial loss of cholinergic neurons and α7 nicotinic receptors (α7AChR) is critical for the gradual cognitive decline. Aβ binds to α7AChR under various experimental settings; nevertheless, the functional significance of this interaction is ambiguous. Whereas the capability of low Aβ concentrations to activate α7AChR is functionally beneficial, extensive brain exposure to high Aβ concentrations diminishes α7AChR activity, contributes to the cholinergic deficits that characterize AD. Aβ and snake α-neurotoxins competitively bind to α7AChR. Accordingly, we designed a chemically modified α-cobratoxin (mToxin) to inhibit the interaction between Aβ and α7AChR. Subsequently, we examined mToxin in a set of original in silico, in vitro, ex vivo experiments, and in a murine AD model. We report that mToxin reversibly inhibits α7AChR, though it attenuates Aβ-induced synaptic transmission abnormalities, and upregulates pathways supporting long-term potentiation and reducing apoptosis. Remarkably, mToxin demonstrates no toxicity in brain slices and mice. Moreover, its chronic intracerebroventricular administration improves memory in AD-model animals. Our results point to unique mToxin neuroprotective properties, which might be tailored for the treatment of AD. Our methodology bridges the gaps in understanding Aβ-α7AChR interaction and represents a promising direction for further investigations and clinical development. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12035-020-02270-0. Springer US 2021-01-08 2021 /pmc/articles/PMC8018932/ /pubmed/33417228 http://dx.doi.org/10.1007/s12035-020-02270-0 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Fonar, Gennadiy Polis, Baruh Sams, Dev Sharan Levi, Almog Malka, Assaf Bal, Natalia Maltsev, Alexander Elliott, Evan Samson, Abraham O. Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer’s Disease Mice |
title | Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer’s Disease Mice |
title_full | Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer’s Disease Mice |
title_fullStr | Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer’s Disease Mice |
title_full_unstemmed | Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer’s Disease Mice |
title_short | Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer’s Disease Mice |
title_sort | modified snake α-neurotoxin averts β-amyloid binding to α7 nicotinic acetylcholine receptor and reverses cognitive deficits in alzheimer’s disease mice |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018932/ https://www.ncbi.nlm.nih.gov/pubmed/33417228 http://dx.doi.org/10.1007/s12035-020-02270-0 |
work_keys_str_mv | AT fonargennadiy modifiedsnakeaneurotoxinavertsbamyloidbindingtoa7nicotinicacetylcholinereceptorandreversescognitivedeficitsinalzheimersdiseasemice AT polisbaruh modifiedsnakeaneurotoxinavertsbamyloidbindingtoa7nicotinicacetylcholinereceptorandreversescognitivedeficitsinalzheimersdiseasemice AT samsdevsharan modifiedsnakeaneurotoxinavertsbamyloidbindingtoa7nicotinicacetylcholinereceptorandreversescognitivedeficitsinalzheimersdiseasemice AT levialmog modifiedsnakeaneurotoxinavertsbamyloidbindingtoa7nicotinicacetylcholinereceptorandreversescognitivedeficitsinalzheimersdiseasemice AT malkaassaf modifiedsnakeaneurotoxinavertsbamyloidbindingtoa7nicotinicacetylcholinereceptorandreversescognitivedeficitsinalzheimersdiseasemice AT balnatalia modifiedsnakeaneurotoxinavertsbamyloidbindingtoa7nicotinicacetylcholinereceptorandreversescognitivedeficitsinalzheimersdiseasemice AT maltsevalexander modifiedsnakeaneurotoxinavertsbamyloidbindingtoa7nicotinicacetylcholinereceptorandreversescognitivedeficitsinalzheimersdiseasemice AT elliottevan modifiedsnakeaneurotoxinavertsbamyloidbindingtoa7nicotinicacetylcholinereceptorandreversescognitivedeficitsinalzheimersdiseasemice AT samsonabrahamo modifiedsnakeaneurotoxinavertsbamyloidbindingtoa7nicotinicacetylcholinereceptorandreversescognitivedeficitsinalzheimersdiseasemice |